TrialJournal of the National Cancer Institute2026
Tamoxifen therapy benefit in luminal A and B breast cancer with 20-year follow-up.
Oscar Danielsson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it